» Articles » PMID: 9482695

Expression of Membrane-type Matrix Metalloproteinase in Rabbit Neointimal Tissue and Its Correlation with Matrix-metalloproteinase-2 Activation

Overview
Journal J Vasc Res
Date 1998 Mar 3
PMID 9482695
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Smooth muscle cell (SMC) phenotypic alteration, followed by migration and proliferation, is a prominent feature of atherogenesis and vascular neointimal formation. Despite extensive research, mechanism(s) responsible for this alteration remain unclear. Recently, matrix metalloproteinases (MMP), a family of potent proteinases, have been implicated in vascular diseases by way of extracellular matrix degradation. Of particular interest is that expression of a 72-kD MMP (MMP-2) is elevated in neointima, and inhibition of this MMP results in reduced SMC migration and proliferation, suggesting a role for MMP-2 in neointimal development. However, MMP-2 needs activation before digesting protein; the mechanism of this activation in the arterial wall is largely unexplored. A novel membrane-type MMP termed MT-MMP-1 has recently been identified, and its expression in tumor cells is concomitant with MMP-2 activation. Transfection of this MMP cDNA into mammalian cells results in activation of MMP-2. However, the importance of this MMP in various pathological situations is not clear. The present study was designed to explore the relationship between MT-MMP- 1 expression and MMP-2 activation during rabbit neointimal development. Using polymerase chain reaction, we isolated a rabbit cDNA from arterial SMC; sequence analysis indicated that it is a rabbit form ofMT-MMP-1. A segment of this cDNA was subcloned into pGEM-3 and employed to synthesize a DIG-labeled RNA probe. This probe was then used in the Northern blot analysis for MT-MMP-1 mRNA expression both in aortic tissue and in neointimal tissues developed 3, 7, 14 and 21 days after balloon catheter de-endothelialization. The results show low-level expression ofMT-MMP-1 in the normal aortic wall; expression is significantly increased in the neointimal tissues, with peak expression observed in tissues 3 days after injury. Expression of active MMP-2 was also determined using gel zymography. A close temporal expression pattern was observed between MT-MMP-1 and active MMP-2. These data verify the expression of MT-MMP-1 in arterial SMC and suggest its importance in MMP-2 activation after balloon catheter de-endothelialization.

Citing Articles

Circulating Matrix Metalloproteinases for Prediction of Aortic Dilatation in Children with Bicuspid Aortic Valve: A Single-Center, Observational Study.

Fagarasan A, Sasaran M, Gozar L, Toma D, Suteu C, Ghiragosian-Rusu S Int J Mol Sci. 2024; 25(19).

PMID: 39408865 PMC: 11476682. DOI: 10.3390/ijms251910538.


The Predictive Role of Plasma Biomarkers in the Evolution of Aortopathies Associated with Congenital Heart Malformations.

Fagarasan A, Sasaran M Int J Mol Sci. 2022; 23(9).

PMID: 35563383 PMC: 9102091. DOI: 10.3390/ijms23094993.


MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation.

Bruczko M, Gogiel T, Wolanska M, Kowalewski R, Sobolewski K, Romanowicz L Int J Exp Pathol. 2019; 100(2):94-101.

PMID: 31058412 PMC: 6540695. DOI: 10.1111/iep.12310.


Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.

Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L Mediators Inflamm. 2013; 2013:928315.

PMID: 23840100 PMC: 3694547. DOI: 10.1155/2013/928315.


Metalloproteinases and plasminogen activators in vessel remodeling.

Bobik A, Tkachuk V Curr Hypertens Rep. 2003; 5(6):466-72.

PMID: 14594565 DOI: 10.1007/s11906-003-0054-5.